INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 411m ago
HOUSE PTR11m ago
SEC 13F11m ago
ROBINHOOD CHAIN11m ago
Corporate insider
DS

Dreyer Scott

EVP & Chief Commercial OfficerCIK 0001746251

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 2
Max Insider Score20
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
DS
Dreyer ScottEVP & Chief Commercial Officer
COLLCOLLEGIUM PHARMACEUTICAL, INC
Option exercise · 10b5-1 plan
M$280K
17.6K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    COLLEGIUM PHARMACEUTICAL, INCEVP & Chief Commercial Officer · Dec 10, 2025
20
DS
Dreyer ScottEVP & Chief Commercial Officer
COLLCOLLEGIUM PHARMACEUTICAL, INC
Open-market sale · 10b5-1 plan
SELL
$533K
11.1K sh
Dec 8, 2025
Dec 10, 2025
traded Dec 8, 2025
+2d
SEC FORM 4

Evidence

20
DS
Dreyer ScottEVP & Chief Commercial Officer
COLLCOLLEGIUM PHARMACEUTICAL, INC
Open-market sale · 10b5-1 plan
SELL$315K
6,475 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence

0
DS
Dreyer ScottEVP & Chief Commercial Officer
COLLCOLLEGIUM PHARMACEUTICAL, INC
Option exercise · 10b5-1 plan
M—
17.6K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC FORM 4

Evidence